Becton, Dickinson And Company: Growth Starts To Normalize (Rating Upgrade)

Natali_Mis/iStock via Getty Images I worried about Becton, Dickinson and Company’s (NYSE:BDX) weak China growth as discussed in my introductory article. On February 1, BD released their Q1 FY24. China declined 5.3% year-over-year, and now the market only represents 6.4% of group revenue. Other major challenges, including the Alaris pump and Covid comparisons, are starting to get normalized, and the stock price is undervalued; therefore, I upgrade the rating from ‘Hold to ‘Buy’ with a fair value of $250  ...